======= PTGDS ======= == Gene Information == * **Official Symbol**: PTGDS * **Official Name**: prostaglandin D2 synthase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5730|5730]] * **UniProt**: [[https://www.uniprot.org/uniprot/P41222|P41222]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PTGDS&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PTGDS|Open PubMed]] * **OMIM**: [[https://omim.org/entry/176803|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Catalyzes the conversion of PGH2 to PGD2, a prostaglandin involved in smooth muscle contraction/relaxation and a potent inhibitor of platelet aggregation. Involved in a variety of CNS functions, such as sedation, NREM sleep and PGE2-induced allodynia, and may have an anti-apoptotic role in oligodendrocytes. Binds small non-substrate lipophilic molecules, including biliverdin, bilirubin, retinal, retinoic acid and thyroid hormone, and may act as a scavenger for harmful hydrophopic molecules and as a secretory retinoid and thyroid hormone transporter. Possibly involved in development and maintenance of the blood-brain, blood-retina, blood-aqueous humor and blood-testis barrier. It is likely to play important roles in both maturation and maintenance of the central nervous system and male reproductive system. {ECO:0000269|PubMed:20667974, ECO:0000269|PubMed:9475419}. |Lipocalin| |prostaglandin-D synthase activity| |retinoid binding| |cyclooxygenase pathway| |regulation of circadian sleep/wake cycle, sleep| |prostaglandin biosynthetic process| |prostanoid biosynthetic process| |regulation of circadian sleep/wake cycle| |fatty acid binding| |prostaglandin metabolic process| |prostanoid metabolic process| |unsaturated fatty acid biosynthetic process| |icosanoid biosynthetic process| |arachidonic acid metabolic process| |rough endoplasmic reticulum| |regulation of behavior| |fatty acid derivative biosynthetic process| |unsaturated fatty acid metabolic process| |icosanoid metabolic process| |regulation of circadian rhythm| |long-chain fatty acid metabolic process| |fatty acid biosynthetic process| |fatty acid derivative metabolic process| |monocarboxylic acid biosynthetic process| |nuclear membrane| |carboxylic acid biosynthetic process| |organic acid biosynthetic process| |fatty acid metabolic process| |monocarboxylic acid metabolic process| |lipid biosynthetic process| |small molecule biosynthetic process| |perinuclear region of cytoplasm| |carboxylic acid metabolic process| |endoplasmic reticulum membrane| |cellular lipid metabolic process| |Golgi apparatus| |oxoacid metabolic process| |organic acid metabolic process| |lipid metabolic process| |extracellular space| |small molecule metabolic process| |extracellular region| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp72|LB-100 4.1μM R02 exp72]]|1.83| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11538 * **Expression level (log2 read counts)**: -1.34 {{:chemogenomics:nalm6 dist.png?nolink |}}